Management of medullary carcinoma of the thyroid during pregnancy in a patient with an intron substitution.
Walshe
Peter
P
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
Seaberg
Raewyn M
RM
Yehuda
Moshe
M
Freeman
Jeremy
J
D000225:Adenine / Q000378:metabolism; D018276:Carcinoma, Medullary / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005091:Exons / Q000235:genetics; D005260:Female; D015316:Genetic Therapy; D006147:Guanine / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D007438:Introns / Q000235:genetics*; D008207:Lymphatic Metastasis / Q000473:pathology; D018813:Multiple Endocrine Neoplasia Type 2a / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D037981:Neck Dissection; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D018566:Pregnancy, High-Risk; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D013961:Thyroid Gland / Q000473:pathology; D013964:Thyroid Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D013965:Thyroidectomy; D005879:Tourette Syndrome; D055815:Young Adult
D006147:Guanine; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; D000225:Adenine